Frontlight ResearchEarly access
Fabry disease trials in France
4 of 7 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in FranceA Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease
- Where
- Garches, Toulouse Cedex 9
- Age
- 18 years to 60 years
- People
- 16 worldwide
- Run by
- Idorsia Pharmaceuticals Ltd.
See details and how to joinNCT07778667 · EU 2026-525207-27-00 - No phaseNot yet taking people in FranceTherapeutic Implications of CMR Low Native T1 in Non-treated Non-hypertrophic Females With Fabry Disease (FD)
- Where
- Bron, Caen, Lille, Limoges, Montpellier, Nîmes, Paris, Pessac, Poitiers, Saint-Herblain, Toulouse
- Age
- 18 years to 50 years
- People
- 60
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT07872852 - Phase 2/3Taking peopleA Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
- Where
- Bordeaux, Montpellier Cedex 5
- Age
- 2 years to 17 years
- People
- 22 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT06328608 · EU 2022-503128-29-00 - No phaseTaking peopleLong Duration Holter ECG in Fabry Disease
- Where
- Paris
- Age
- 18 years and over
- People
- 40
- Run by
- Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT04440254